West Family Investments’s Cidara Therapeutics CDTX Stock Holding History

West Family Investments’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-18,446	Closed	-$348K	–	247
2023 Q3	$348K	Hold	18,446	–	–	0.12%	134
2023 Q2	$417K	Hold	18,446	–	–	0.16%	114
2023 Q1	$469K	Hold	18,446	–	–	0.19%	89
2022 Q4	$279K	Hold	18,446	–	–	0.1%	174
2022 Q3	$232K	Hold	18,446	–	–	0.1%	184
2022 Q2	$180K	Hold	18,446	–	–	0.07%	216
2022 Q1	$307K	Hold	18,446	–	–	0.09%	190
2021 Q4	$469K	Hold	18,446	–	–	0.13%	136
2021 Q3	$826K	Hold	18,446	–	–	0.21%	87
2021 Q2	$745K	Hold	18,446	–	–	0.2%	83
2021 Q1	$981K	Hold	18,446	–	–	0.36%	66
2020 Q4	$738K	Hold	18,446	–	–	0.22%	87
2020 Q3	$1.05M	Buy	18,446 +3,446	+23%	+$243K	0.39%	52
2020 Q2	$1.15M	Sell	15,000 -3,446	-19%	-$223K	0.28%	58
2020 Q1	$915K	Buy	18,446 +3,446	+23%	+$206K	0.36%	50
2019 Q4	$1.15M	Hold	15,000	–	–	0.28%	58
2019 Q3	$599K	Hold	15,000	–	–	0.15%	65
2019 Q2	$504K	Buy	15,000 +4,406	+42%	+$183K	0.13%	71
2019 Q1	$561K	Buy	10,594 +594	+6%	+$32.6K	0.14%	70
2018 Q4	$470K	Hold	10,000	–	–	0.12%	77
2018 Q3	$880K	Buy	10,000 +2,306	+30%	+$203K	0.21%	66
2018 Q2	$800K	Buy	7,694 +2,694	+54%	+$254K	0.2%	63
2018 Q1	$400K	Hold	5,000	–	–	0.11%	74
2017 Q4	$680K	Hold	5,000	–	–	0.17%	70
2017 Q3	$810K	Hold	5,000	–	–	0.1%	66
2017 Q2	$750K	Hold	5,000	–	–	0.16%	73
2017 Q1	$780K	Buy	+5,000	New	+$878K	0.15%	70

Other funds holding CDTX

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

ACM

Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

West Family Investments's CDTX Position: Q4 2023 in Review

West Family Investments sold out of Cidara Therapeutics (CDTX) in Q4 2023, closing a stake of 18,446 shares — an estimated $348K sold.

West Family Investments first reported a position in CDTX in Q1 2017 and held it in 27 quarters. The position peaked at $1.15M in Q2 2020. 51 funds tracked by Wall St. Rank hold CDTX as of Q4 2023.

West Family Investments reported no remaining Cidara Therapeutics position as of Q4 2023 after selling out during the quarter.
West Family Investments sold 18,446 Cidara Therapeutics shares in Q4 2023, an estimated $348K.
West Family Investments first reported a position in Cidara Therapeutics in Q1 2017 and held it in 27 quarters.
West Family Investments's Cidara Therapeutics position peaked at $1.15M in Q2 2020.
51 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q4 2023.

Based on West Family Investments's 13F filing for Q4 2023, filed 6 Feb 2024.